Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Pei-Ying Pai"'
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 9, Iss 8, p 266 (2022)
Background: The present study investigated whether angiotensin II type 1 receptor blocker irbesartan (ARB) and partial agonist of PPAR-γ prevents heart apoptosis by suppressing cardiac Fas/FasL-mediated to mitochondria-mediated apoptosis in the hear
Externí odkaz:
https://doaj.org/article/3723bdfb205f4247824c45293de88127
Autor:
Chih-Yang Huang, Chia-Hua Kuo, Pei-Ying Pai, Tsung-Jung Ho, Yueh-Min Lin, Ray-Jade Chen, Fuu-Jen Tsai, V. Vijaya Padma, Wei-Wen Kuo
Publikováno v:
Data in Brief, Vol 16, Iss , Pp 521-526 (2018)
In association with the published article “Inhibition of HSF2 SUMOylation via MEL18 upregulates IGF-IIR and leads to hypertension-induced cardiac hypertrophy” (Huang et al., 2017) [1], this data article contains information about deSUMOylation of
Externí odkaz:
https://doaj.org/article/007251f1ebfd4a0b99fbf20b092e89b7
Autor:
Ruey-Lin Chang, Srinivasan Nithiyanantham, Chih-Yang Huang, Pei-Ying Pai, Tung-Ti Chang, Lai-Chin Hu, Ray-Jade Chen, V VijayaPadma, Wei-Wen Kuo
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0216285 (2019)
Stress-induced cardiac hypertrophy leads to heart failure. Our previous studies demonstrate that insulin-like growth factor-II receptor (IGF-IIR) signaling is pivotal to hypertrophy regulation. In this study, we show a novel IGF-IIR alternative splic
Externí odkaz:
https://doaj.org/article/856059255b3a4b6181fddd8bcf7817ea
Autor:
Pei-Ying Pai, 白培英
104
Background: Only very limited information regarding the protective effects of the superoxide anion scavenger on chronic intermittent hypoxia-induced cardiac apoptosis is available. With aging, cardiomyocytes undergo complex changes, which fi
Background: Only very limited information regarding the protective effects of the superoxide anion scavenger on chronic intermittent hypoxia-induced cardiac apoptosis is available. With aging, cardiomyocytes undergo complex changes, which fi
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/449nyq
Autor:
Pei-Ying, Pai, Yi-Yuan, Lin, Shao-Hong, Yu, Ching-Yuang, Lin, Yi-Fan, Liou, Xu-Bo, Wu, James K S, Wong, Chih-Yang, Huang, Shin-Da, Lee
Publikováno v:
Sleepbreathing = SchlafAtmung. 26(3)
The purpose of this study was to investigate whether or not angiotensin II type 1 receptor blocker irbesartan (ARB) with a partial agonist of PPAR-γ could protect against chronic nocturnal intermittent hypoxia (CIH)-induced cardiac Fas/FasL-mediated
Autor:
Sudhir Pandey, Wei‐Wen Kuo, Tsung‐Jung Ho, Yu‐Lan Yeh, Chia‐Yao Shen, Ray‐Jade Chen, Ruey‐Lin Chang, Pei‐Ying Pai, V. Vijaya Padma, Chih‐Yang Huang
Publikováno v:
Journal of Cellular Biochemistry. 120:16956-16966
Cardiotoxicity by doxorubicin hampers its therapeutic potential as an anticancer drug, but mechanisms leading to cardiotoxicity remain contentious. Through this study, the functional contribution of insulin-like growth factor receptor type II α (IGF
Autor:
Ruey-Lin Chang, Srinivasan Nithiyanantham, Wei-Wen Kuo, Pei-Ying Pai, Tung-Ti Chang, Chao-Hung Lai, Ray-Jade Chen, Viswanadha Vijaya Padma, Chih-Yang Huang
Publikováno v:
Environmental Toxicology. 34:210-218
IGF-IIR activation regulates cardiac remodeling leading to apoptosis. Here, we identified the novel IGF-IIRα (150 KDa), a truncated IGF-IIR transcript enhances cardiac apoptosis under high-salt uptake in transgenic rat model. Echocardiographic analy
Autor:
Chih-Yang Huang, Chia-Hua Kuo, Pei-Ying Pai, Tsung-Jung Ho, Yueh-Min Lin, Ray-Jade Chen, Fuu-Jen Tsai, V. Vijaya Padma, Wei-Wen Kuo
Publikováno v:
Data in Brief
Data in Brief, Vol 16, Iss, Pp 521-526 (2018)
Data in Brief, Vol 16, Iss, Pp 521-526 (2018)
In association with the published article “Inhibition of HSF2 SUMOylation via MEL18 upregulates IGF-IIR and leads to hypertension-induced cardiac hypertrophy” (Huang et al., 2017) [1] , this data article contains information about deSUMOylation o
Autor:
Chih‐Yang Huang, Jia‐Yi Chen, Chia‐Hua Kuo, Pei‐Ying Pai, Tsung‐Jung Ho, Tung‐Sheng Chen, Fu‐Jen Tsai, Vijaya V. Padma, Wei‐Wen Kuo
Publikováno v:
Journal of Cellular Physiology. 233:463-475
Doxorubicin (DOX), one useful chemotherapeutic agent, is limited in clinical use because of its serious cardiotoxicity. Growing evidence suggests that angiotensin receptor blockers (ARBs) have cardioprotective effects in DOX-induced cardiomyopathy. H
Autor:
Sudhir Pandey, Wei-Wen Kuo, Chia-Yao Shen, Yu-Lan Yeh, Tsung-Jung Ho, Ray-Jade Chen, Ruey-Lin Chang, Pei-Ying Pai, Vijaya Padma Viswanadha, Chih-Yang Huang
Publikováno v:
American journal of physiology. Cell physiology. 317(2)
Doxorubicin (DOX) is an anthracycline antibiotic commonly employed for the treatment of various cancers. However, its therapeutic uses are hampered by side effects associated with cumulative doses during the course of treatment. Whereas deregulation